Clinical Trials in Turkey / NCT07282431
Active, not recruiting
Not applicable
Shockwave Therapy Plus Exercise for Lateral Epicondylitis
NCT07282431 · tracked via the Priya Life Science Turkey tracker
Condition(s) studied
Lateral Epicondylitis
Investigational drug(s) / intervention(s)
Extracorporeal Shock Wave Therapy (ESWT)exercise therapy
Extracorporeal Shock Wave Therapy (ESWT): Extracorporeal Shock Wave Therapy (ESWT)
exercise therapy: exercise therapy
Study summary
The primary objective of this study is to compare the clinical effectiveness of exercise therapy alone versus exercise combined with Extracorporeal Shock Wave Therapy (ESWT) in individuals with lateral epicondylitis, focusing on changes in pain, grip strength, functional status, and overall treatment success.
Eligibility
Inclusion Criteria: Individuals with the following characteristics will be included in the study:
* Being 18 years of age or older
* Having a clinical diagnosis of lateral epicondylitis
* Not having received any other similar treatment within the last 6 months
* Having the cognitive ability to understand the Turkish questionnaire and assessment forms
* Voluntarily agreeing to participate in the study and providing written informed consent
Exclusion Criteria: Individuals with one or more of the following conditions will be excluded from the study:
* Having a history of concomitant systemic, rheumatological, or inflammatory diseases that could affect pain
* Having a history of trauma, surgery, or neurological disease in the upper extremity
* Presence of conditions other than lateral epicondylitis, such as tendinopathy, bursitis, or nerve entrapment
* Having major psychiatric disorders that could affect the pain threshold (e.g., major depression, schizophrenia)
Primary outcome measure(s)
- Extracorporeal Shock Wave Therapy (ESWT) applied in addition to exercise does not create a significant difference in pain level, grip strength and functional status in individuals with lateral epicondylitis compared to exercise alone. — 8 week
Pain Intensity (Visual Analog Scale - VAS) Description: Pain intensity will be assessed using the Visual Analog Scale, a 10-cm line ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will mark their perceived pain level on the line. Time Frame: Baseline and 8 weeks Outcome Type: Continuous Interpretation: Higher scores indicate worse pain. - Upper Extremity Function (Quick Disabilities of the Arm, Shoulder and Hand Questionnaire - QuickDASH) — 8 week
Upper Extremity Function (Quick Disabilities of the Arm, Shoulder and Hand Questionnaire - QuickDASH) Description: Functional status will be measured using the QuickDASH questionnaire. Scores range from 0 (no disability) to 100 (severe disability). Time Frame: Baseline and 8 weeks Outcome Type: Continuous Interpretation: Higher scores indicate worse functional impairment.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Istanbul medipol University | Istanbul | Beykoz |
More Istanbul Medipol University Hospital trials in Turkey
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07282431 on ClinicalTrials.gov ↗ ← All trials in Turkey